Ingles Markets Inc (NASDAQ: IMKTA) has reported E.P.S. of $1.68 for its second fiscal quarter (ending March 31) versus $2.13 for the same period a year ago — a decline of -21%. E.P.S. were $9.27 […]
For its first fiscal quarter (ending March 31), ICL GROUP LTD (NYSE: ICL) has reported a -64% decline in E.P.S. from $0.22 a year ago to $0.08 in the current quarter. This performance was $-0.02 […]
Gen Digital Inc (NASDAQ: GEN) has reported E.P.S. of $0.21 for its fourth fiscal quarter (ending March 31) versus $1.43 for the same period a year ago — a decline of -85%. Relative to the […]
Forward Air Corp (NASDAQ: FWRD) stock suffered a major decline of -22.1% on 5/9/24. The shares closed at $16.76. Moreover, exceptionally high trading volume at 467% of normal accompanied the decline. Relative to the market […]
Evolent Health Inc (NYSE: EVH) has reported a loss for its first fiscal quarter (ending March 31) of $-0.22 versus a loss $-0.24 for the same period a year ago. Relative to the consensus estimate […]
Editas Medicine Inc (NASDAQ: EDIT) stock enjoyed a major increase of 10.4% on 5/9/24. The shares closed at $5.56. Moreover, this advance was accompanied by above average trading volume at 142% of normal. Relative to […]
Cogent Communications Holdings I (NASDAQ: CCOI) has reported E.P.S. of $-1.38 for its first fiscal quarter (ending March 31) versus $0.13 for the same period a year ago — a decline of -1162%. Relative to […]
Charles River Laboratories Inter (NYSE: CRL) has reported earnings for its first fiscal quarter (ending March 31) of $1.31 versus $2.02 for the same period a year ago — a decline of -35%. This result […]
Ceva Inc (NASDAQ: CEVA) has reported a loss for its first fiscal quarter (ending March 31) of $-0.23 versus a loss $-0.12 for the same period a year ago. This result fell short of the […]
Central Garden & Pet Co (NASDAQ: CENTA) stock closed at $39.99 on 5/9/24 after a major increase of 11.3%. Moreover, unusually high trading volume at 176% of normal accompanied the advance. The stock has risen […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research